Osterloh Albert Frederick IV 4

What Happened

• Albert Frederick Osterloh IV, a director of DexCom, Inc. (DXCM), was granted 1,630 restricted stock units (RSUs) on May 28, 2026. The award was recorded at $0.00 per share (RSUs represent a contingent right to receive one share upon settlement).

Key Details

• Transaction date and terms: May 28, 2026 — Grant/award of 1,630 RSUs at $0.00 per RSU (no cash purchase).
• Vesting: 100% of the 1,630 RSUs vest on the earlier of the one-year anniversary of the grant (May 28, 2027) or DexCom’s 2027 Annual Meeting of Stockholders. (Footnote F1)
• Shares owned after transaction: Filing indicates 8,691 unvested RSUs in total beneficially held, which includes the 1,630 RSUs granted May 28, 2026 and 7,061 RSUs granted Feb 26, 2026 that vest through Feb 26, 2029. (Footnote F2)
• Timeliness: Form 4 was filed on June 1, 2026 covering the May 28, 2026 grant; this filing is within the SEC’s two-business-day reporting window.

Context

• This was an equity award (compensation/retention grant), not an open-market purchase or sale. RSUs are not immediate cash inflows — they convert to common shares upon vesting/settlement and do not necessarily indicate buying or selling sentiment.